Articles by The Wall Street Analyzer

About The Wall Street Analyzer
The Wall Street Analyzer's staff of writers, analysts, publishers, producers, market researchers, and PR professionals aim to provide investors with the tools they need to make informed decisions on buying stock. Our staff is a mix of financial professionals and media savvy individuals whose experiences bring the best talent from both ends of the spectrum.
No Picture
Spotlight

The Wall Street Analyzer recently interviewed David D’Onofrio, the CEO of White Gold Corporation (TSX.V: WGO) (US OTC – NASDAQ International: WHGOF) to discuss the company’s recent impressive drill results at their new Vertigo discovery on their JP Ross Property, located in the Yukon territory.

November 20, 2018 The Wall Street Analyzer Comments Off on The Wall Street Analyzer recently interviewed David D’Onofrio, the CEO of White Gold Corporation (TSX.V: WGO) (US OTC – NASDAQ International: WHGOF) to discuss the company’s recent impressive drill results at their new Vertigo discovery on their JP Ross Property, located in the Yukon territory.

  The Wall Street Analyzer recently interviewed David D’Onofrio, the CEO of White Gold Corporation (TSX.V: WGO) (US OTC – NASDAQ International: WHGOF) to discuss the company’s recent impressive drill results at their new Vertigo […]

News Feed

Kratos Receives $15.2 Million in Unmanned Drone System Contract Awards

November 8, 2018 The Wall Street Analyzer Comments Off on Kratos Receives $15.2 Million in Unmanned Drone System Contract Awards

Steve Fendley, President of Kratos Unmanned Systems Division, said, “The Global Recapitalization of strategic weapon systems by the U.S. and its allies to address peer and near peer threats is driving strong demand for Kratos’ threat representative target drone systems. These recent contract awards reflect our customers’ desire to exercise their Next Generation weapon systems against the most realistic threat representative scenarios possible.” […]

News Feed

Persistent Use of Valeritas’ V-Go® Wearable Insulin Delivery Device Demonstrates Significant Clinical & Economic Benefits Compared to Conventional Insulin Delivery in Patients with Type 2 Diabetes

October 10, 2018 The Wall Street Analyzer Comments Off on Persistent Use of Valeritas’ V-Go® Wearable Insulin Delivery Device Demonstrates Significant Clinical & Economic Benefits Compared to Conventional Insulin Delivery in Patients with Type 2 Diabetes

“We are very encouraged with both the clinical and economic benefits patients experienced in our study while utilizing V-Go to manage their diabetes,” said Beverly Everitt, APRN, MSN, CDE, BC-ADM, lead author and investigator from Endocrinology Consultants. […]